Tokyo Tape
Sign in
← J Frontier

Annual report

2934.TEDINET S100P44C
Period2021-06-01 → 2022-05-31
Filed2022-08-31
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 98
MetricValuePeriodScopeSource row
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales
Operating income¥732m2021-06-01 → 2022-05-31Cons.Operating income
Ordinary income¥713m2021-06-01 → 2022-05-31Cons.Ordinary income
Profit before tax¥702m2021-06-01 → 2022-05-31Cons.Income before income taxes
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income¥400m2021-06-01 → 2022-05-31Cons.Profit loss
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥1.3bnat 2021-05-31Cons.Net assets
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥3.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2021-05-31Cons.Cash and cash equivalents
Operating cash flow−¥367m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥860m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥2.6bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥907.43at 2022-05-31Cons.Net assets per share (5-year summary)
Equity ratio68.2%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
ROE9.7%2021-06-01 → 2022-05-31Cons.Rate of return on equity (5-year summary)
Employees278at 2022-05-31Cons.Number of employees
Revenue¥9.3bn2021-06-01 → 2022-05-31StandaloneNet sales
Revenue¥8.5bn2020-06-01 → 2021-05-31StandaloneNet sales
Revenue¥7.1bn2019-06-01 → 2020-05-31dStandaloneNet sales (5-year summary)
Revenue¥6.1bn2018-06-01 → 2019-05-31dStandaloneNet sales (5-year summary)
Revenue¥5.2bn2017-06-01 → 2018-05-31dStandaloneNet sales (5-year summary)
Operating income¥751m2021-06-01 → 2022-05-31StandaloneOperating income
Operating income¥672m2020-06-01 → 2021-05-31StandaloneOperating income
Ordinary income¥724m2021-06-01 → 2022-05-31StandaloneOrdinary income
Ordinary income¥679m2020-06-01 → 2021-05-31StandaloneOrdinary income
Ordinary income¥174m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥367m2018-06-01 → 2019-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥589m2017-06-01 → 2018-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥723m2021-06-01 → 2022-05-31StandaloneIncome before income taxes
Profit before tax¥679m2020-06-01 → 2021-05-31StandaloneIncome before income taxes
Net income¥450m2021-06-01 → 2022-05-31StandaloneProfit loss
Net income¥425m2020-06-01 → 2021-05-31StandaloneProfit loss
Net income¥96m2019-06-01 → 2020-05-31dStandaloneNet income loss (5-year summary)
Net income¥6m2018-06-01 → 2019-05-31dStandaloneNet income loss (5-year summary)
Net income¥399m2017-06-01 → 2018-05-31dStandaloneNet income loss (5-year summary)
Total assets¥5.3bnat 2022-05-31StandaloneAssets
Total assets¥2.6bnat 2021-05-31StandaloneAssets
Total assets¥2.0bnat 2020-05-31dStandaloneTotal assets (5-year summary)
Total assets¥1.9bnat 2019-05-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2018-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.1bnat 2022-05-31StandaloneLiabilities
Total liabilities¥1.3bnat 2021-05-31StandaloneLiabilities
Net assets / equity¥4.2bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.3bnat 2021-05-31StandaloneNet assets
Net assets / equity¥843mat 2020-05-31dStandaloneNet assets
Net assets / equity¥746mat 2019-05-31dStandaloneNet assets (5-year summary)
Net assets / equity¥739mat 2018-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.4bnat 2022-05-31StandaloneCash and deposits
Cash and deposits¥1.6bnat 2021-05-31StandaloneCash and deposits
Cash & equivalents¥1.6bnat 2021-05-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥902mat 2020-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥948mat 2019-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥831m2020-06-01 → 2021-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥218m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥14m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2020-06-01 → 2021-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥165m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥63m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥94m2020-06-01 → 2021-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥99m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥130m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥101.912021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥110.752020-06-01 → 2021-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.122019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1.62018-06-01 → 2019-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥207.982017-06-01 → 2018-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥97.452021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥918.35at 2022-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥329.99at 2021-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥219.25at 2020-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥194.13at 2019-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥385.07at 2018-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio79.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.8%at 2021-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio41.5%at 2020-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio39.0%at 2019-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio49.6%at 2018-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.5%2021-06-01 → 2022-05-31StandaloneRate of return on equity (5-year summary)
ROE40.3%2020-06-01 → 2021-05-31StandaloneRate of return on equity (5-year summary)
ROE12.2%2019-06-01 → 2020-05-31dStandaloneRate of return on equity (5-year summary)
ROE0.8%2018-06-01 → 2019-05-31dStandaloneRate of return on equity (5-year summary)
ROE74.0%2017-06-01 → 2018-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued4,757,616at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2021-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2020-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2019-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2018-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees54at 2022-05-31StandaloneNumber of employees
Employees46at 2021-05-31StandaloneNumber of employees
Employees47at 2020-05-31dStandaloneNumber of employees
Employees42at 2019-05-31dStandaloneNumber of employees
Employees37at 2018-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2021-06-01 → 2022-05-31¥5m
Reconciling Itemsreconcilingdepreciation2021-06-01 → 2022-05-31¥5m
Reconciling Itemsreconcilingrevenue2021-06-01 → 2022-05-31−¥54m
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2022-05-31−¥54m
Reconciling Itemsreconcilingsegment assetsat 2022-05-31¥2.7bn
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-05-31−¥425m
Healthcare Marketing Businessreportable segmentcapex2021-06-01 → 2022-05-31¥362m
Healthcare Marketing Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥2m
Healthcare Marketing Businessreportable segmentemployeesat 2022-05-3199 pure
Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥3.9bn
Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥3.8bn
Healthcare Marketing Businessreportable segmentrevenue intersegment2021-06-01 → 2022-05-31¥54m
Healthcare Marketing Businessreportable segmentsegment assetsat 2022-05-31¥1.3bn
Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥37m
Healthcare Sales Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥703,000
Healthcare Sales Businessreportable segmentemployeesat 2022-05-3123 pure
Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥3.0bn
Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥3.0bn
Healthcare Sales Businessreportable segmentsegment assetsat 2022-05-31¥251m
Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥779m
Medical Care Sales Businessreportable segmentcapex2021-06-01 → 2022-05-31¥544m
Medical Care Sales Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥3m
Medical Care Sales Businessreportable segmentemployeesat 2022-05-31142 pure
Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥5.0bn
Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥5.0bn
Medical Care Sales Businessreportable segmentsegment assetsat 2022-05-31¥1.8bn
Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥340m
—segment totalemployeesat 2022-05-31278 pure
Total Of Reportable Segments And Otherssegment totalcapex2021-06-01 → 2022-05-31¥907m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-06-01 → 2022-05-31¥5m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-05-31¥11.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-05-31¥11.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-06-01 → 2022-05-31¥54m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-05-31¥3.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-05-31¥1.2bn
Healthcare Marketing Businessreportable segmentemployeesat 2022-05-3110 pure
Healthcare Sales Businessreportable segmentemployeesat 2022-05-3123 pure
Medical Care Sales Businessreportable segmentemployeesat 2022-05-3110 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,094
ItemContextValueUnit
Amortization of long term prepaid expenses sgaCurrentYearDuration2228000JPY
Provision for bonuses sgaCurrentYearDuration7855000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration762000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration8230000JPY
Revenues from external customersCurrentYearDuration_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember4988568000JPY
Revenues from external customersCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember3043248000JPY
Revenues from external customersCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember3844864000JPY
Revenues from external customersCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember11876681000JPY
Revenues from external customersCurrentYearDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYearDuration11876681000JPY
Transactions with other segmentsCurrentYearDuration_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember53613000JPY
Transactions with other segmentsCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember53613000JPY
Transactions with other segmentsCurrentYearDuration_ReconcilingItemsMember-53613000JPY
Transactions with other segmentsCurrentYearDuration－JPY
Net salesCurrentYearDuration_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember4988568000JPY
Net salesCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember3043248000JPY
Net salesCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember3898478000JPY
Net salesCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember11930295000JPY
Net salesCurrentYearDuration_ReconcilingItemsMember-53613000JPY
Net salesCurrentYearDuration11876681000JPY
Operating incomeCurrentYearDuration_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember339874000JPY
Operating incomeCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember779434000JPY
Operating incomeCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember37454000JPY
Operating incomeCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember1156763000JPY
Operating incomeCurrentYearDuration_ReconcilingItemsMember-424523000JPY
Operating incomeCurrentYearDuration732239000JPY
AssetsCurrentYearInstant_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember1844875000JPY
AssetsCurrentYearInstant_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember251382000JPY
AssetsCurrentYearInstant_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember1267359000JPY
AssetsCurrentYearInstant_TotalOfReportableSegmentsAndOthersMember3363617000JPY
AssetsCurrentYearInstant_ReconcilingItemsMember2696920000JPY
AssetsCurrentYearInstant6060538000JPY
Depreciation segment informationCurrentYearDuration_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember3112000JPY
Depreciation segment informationCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember703000JPY
Depreciation segment informationCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember1610000JPY
Depreciation segment informationCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember5425000JPY
Depreciation segment informationCurrentYearDuration_ReconcilingItemsMember4844000JPY
Depreciation segment informationCurrentYearDuration10270000JPY
Amortization of goodwill sgaCurrentYearDuration_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember27253000JPY
Amortization of goodwill sgaCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember－JPY
Amortization of goodwill sgaCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember20175000JPY
Amortization of goodwill sgaCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember47429000JPY
Amortization of goodwill sgaCurrentYearDuration_ReconcilingItemsMember－JPY
Amortization of goodwill sgaCurrentYearDuration47429000JPY
Unamortized balance of goodwillCurrentYearDuration_jpcrp030000-asr_E33800-000MedicalCareSalesBusinessReportableSegmentMember540331000JPY
Unamortized balance of goodwillCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareSalesBusinessReportableSegmentMember－JPY
Unamortized balance of goodwillCurrentYearDuration_jpcrp030000-asr_E33800-000HealthcareMarketingBusinessReportableSegmentMember336335000JPY
Unamortized balance of goodwillCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember876666000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2021-05-31pass
balance sheet identitynon_consolidated 2022-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2020-05-31pass
statement vs summary · net assetsnon_consolidated 2021-05-31pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2022-05-31pass
statement vs summary · revenueconsolidated 2021-06-01/2022-05-31pass
statement vs summary · revenuenon_consolidated 2020-06-01/2021-05-31pass
statement vs summary · revenuenon_consolidated 2021-06-01/2022-05-31pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2021-05-31pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass